|
|
||||||||
1Medical Microbiology, Centre for Infectious Diseases, The University of Edinburgh Medical School, Teviot Place, Edinburgh EH8 9AG, UK 2Geriatric Medicine Unit, University of Edinburgh, Royal Victoria Hospital, Craigleith Road, Edinburgh EH4 2DN, UK
Correspondence Ian R. Poxton i.r.poxton{at}ed.ac.uk
Received January 16, 2003
Accepted April 2, 2003
Clostridium difficile is the major identifiable cause of antibiotic-associated diarrhoea in the UK. The aim of this study was to employ traditional culture, toxin detection and a novel typing method to determine the level of C. difficile colonization and disease in a population of elderly patients and to investigate the association between strains in the patients and their environment. Three hundred and ninety patients between 62 and 101 years of age admitted to a geriatric unit in the Royal Victoria Hospital (RVH), Edinburgh, were investigated for the presence of C. difficile. C. difficile was cultured from 100 (26 %) patients using pre-reduced cycloserine-cefoxitin egg yolk agar, and toxin(s) was detected in the faeces of 34 of these patients using the Techlab ELISA test kit for the detection of C. difficile toxins A and/or B. Toxin(s) was detected in a further 18 patients from whom no C. difficile was detected in culture. Of the patients in whom C. difficile was detected, 49 % had diarrhoea, with the highest proportion of patients with diarrhoea being both culture- and toxin-positive for C. difficile. Environmental sampling of the patient environment yielded C. difficile from 14 % of samples. The organism was most frequently isolated from floors, sluice-rooms and toilet areas. The variation in the molecular mass of the C. difficile S-layer proteins was exploited as the basis of a novel typing method for C. difficile. Isolates from patients in the RVH were given a four-digit S-type number based on their S-layer protein profile. A total of seven S-types were identified, with one type, toxigenic S-type 5236, accounting for 73 % of all clinical isolates and 91 % of environmental isolates.
This article has been cited by other articles:
![]() |
E. Mutlu, A. J. Wroe, K. Sanchez-Hurtado, J. S. Brazier, and I. R. Poxton Molecular characterization and antimicrobial susceptibility patterns of Clostridium difficile strains isolated from hospitals in south-east Scotland J. Med. Microbiol., July 1, 2007; 56(7): 921 - 929. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Poilane, C. Humeniuk-Ainouz, I. Durand, C. Janoir, P. Cruaud, M. Delmee, M. R. Popoff, and A. Collignon Molecular characterization of Clostridium difficile clinical isolates in a geriatric hospital J. Med. Microbiol., March 1, 2007; 56(3): 386 - 390. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Starr Clostridium difficile associated diarrhoea: diagnosis and treatment BMJ, September 3, 2005; 331(7515): 498 - 501. [Full Text] [PDF] |
||||
![]() |
I. R Poxton Clostridium difficile J. Med. Microbiol., February 1, 2005; 54(2): 97 - 100. [Full Text] [PDF] |
||||
![]() |
L. J. Drummond, D. G.E. Smith, and I. R. Poxton Effects of sub-MIC concentrations of antibiotics on growth of and toxin production by Clostridium difficile J. Med. Microbiol., December 1, 2003; 52(12): 1033 - 1038. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | J MED MICROBIOL | MICROBIOLOGY | J GEN VIROL | ALL SGM JOURNALS |